This study makes the first attempt to perform gene therapy using a minicircle DNA (MC‐DNA) vector expressing a fragment of FGF23 (amino acids 180‐251) in Phex‐T1349C mice and suggests MC‐DNA as a promisingly safe and effective therapeutic strategy to treat XLHR. Here, FGF23 is linked to X-linked dominant hypophosphatemic rickets.